Evolent Health Company Top Insiders
| EVH Stock | USD 4.02 0.07 1.77% |
Evolent Health's insiders are aggressively buying. The analysis of the overall insider sentiment regarding Evolent Health suggests that almost all insiders are extremely bullish. Evolent Health employs about 4.5 K people. The company is managed by 39 executives with a total tenure of roughly 156 years, averaging almost 4.0 years of service per executive, having 115.38 employees per reported executive.
| Seth Blackley CEO Chief Executive Officer, Co-Founder, Director |
| Frank Williams Chairman Co-Founder, CEO, Director and Chairman of Nominating and Governance Committee |
Insider Sentiment 100
Aggressively Buying
Selling | Buying |
Latest Trades
| 2025-03-06 | Seth Blackley | Acquired 55225 @ 9.01 | View | ||
| 2025-03-04 | Brendan B Springstubb | Acquired 5000 @ 8.75 | View |
Monitoring Evolent Health's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. Evolent Health's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Evolent Health's future performance. Based on our forecasts, it is anticipated that Evolent will maintain a workforce of under 4500 employees by February 2026.Evolent Health's latest congressional trading
Congressional trading in companies like Evolent Health, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Evolent Health by those in governmental positions are based on the same information available to the general public.
| 2020-05-29 | Representative Greg Gianforte | Acquired $50K to $100K | Verify |
Evolent Health Management Team Effectiveness
The current Return On Tangible Assets is estimated to decrease to -0.08. The current Return On Capital Employed is estimated to decrease to -0.02. As of now, Evolent Health's Other Current Assets are increasing as compared to previous years. The Evolent Health's current Intangible Assets is estimated to increase to about 821.3 M, while Non Currrent Assets Other are projected to decrease to under 25.9 M. Evolent Health's management efficiency ratios could be used to measure how well Evolent Health manages its routine affairs as well as how well it operates its assets and liabilities.The current Common Stock Shares Outstanding is estimated to decrease to about 77.9 M. The current Net Loss is estimated to decrease to about (88.3 M)The majority of Evolent Health outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Evolent Health to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Evolent Health. Please pay attention to any change in the institutional holdings of Evolent Health as this could imply that something significant has changed or is about to change at the company. Please note that on May 29, 2020, Representative Greg Gianforte of US Congress acquired $50k to $100k worth of Evolent Health's common stock.
Shares in Circulation | First Issued 2013-12-31 | Previous Quarter 115.9 M | Current Value 114.1 M | Avarage Shares Outstanding 77.8 M | Quarterly Volatility 27.3 M |
Evolent Health Workforce Comparison
Evolent Health is one of the top stocks in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 13,681. Evolent Health totals roughly 4,500 in number of employees claiming about 33% of equities under Health Care industry.
The company has Net Profit Margin of (0.06) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. Evolent Health Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Evolent Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Evolent Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Evolent Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2025-09-01 | 4.0 | 4 | 1 | 160,772 | 2,567 |
| 2025-03-01 | 2.0 | 24 | 12 | 1,130,494 | 224,838 |
| 2024-09-01 | 0.4 | 6 | 15 | 234,594 | 519,759 |
| 2024-03-01 | 0.8462 | 11 | 13 | 391,263 | 206,018 |
| 2023-12-01 | 0.25 | 2 | 8 | 283,000 | 433,490 |
| 2023-09-01 | 0.2857 | 2 | 7 | 13,386 | 50,482 |
| 2023-06-01 | 0.6522 | 15 | 23 | 481,432 | 903,009 |
| 2023-03-01 | 0.5152 | 17 | 33 | 1,546,302 | 1,959,501 |
| 2022-12-01 | 0.3 | 3 | 10 | 295,000 | 590,000 |
| 2022-09-01 | 0.2727 | 3 | 11 | 217,247 | 509,955 |
| 2022-06-01 | 9.0 | 9 | 1 | 50,076 | 3,860 |
| 2022-03-01 | 0.4583 | 11 | 24 | 836,298 | 966,247 |
| 2021-12-01 | 0.3846 | 5 | 13 | 183,405 | 390,000 |
| 2021-09-01 | 0.4762 | 20 | 42 | 175,318 | 402,716 |
| 2021-06-01 | 1.1818 | 13 | 11 | 119,417 | 125,052 |
| 2021-03-01 | 7.0 | 7 | 1 | 164,590 | 0.00 |
| 2020-09-01 | 0.5 | 1 | 2 | 10,000 | 20,000 |
| 2020-06-01 | 1.3333 | 8 | 6 | 268,114 | 99,530 |
| 2020-03-01 | 6.0 | 6 | 1 | 530,219 | 0.00 |
| 2019-09-01 | 0.4 | 2 | 5 | 22,200 | 80,222 |
| 2018-09-01 | 0.3103 | 9 | 29 | 245,440 | 735,559 |
| 2018-06-01 | 0.5625 | 9 | 16 | 58,672 | 3,189,979 |
| 2018-03-01 | 6.0 | 12 | 2 | 2,486,174 | 4,812,898 |
| 2017-09-01 | 0.3077 | 4 | 13 | 27,700 | 114,507 |
| 2017-06-01 | 0.403 | 27 | 67 | 8,034,433 | 20,455,695 |
| 2017-03-01 | 0.6071 | 17 | 28 | 4,713,444 | 11,742,278 |
| 2016-09-01 | 0.5238 | 11 | 21 | 2,037,829 | 10,427,023 |
| 2016-06-01 | 1.0 | 1 | 1 | 8,183 | 0.00 |
| 2015-12-01 | 2.0 | 2 | 1 | 12,954 | 0.00 |
| 2015-06-01 | 0.0227 | 1 | 44 | 2,000 | 13,768,760 |
Evolent Health Notable Stakeholders
An Evolent Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Evolent Health often face trade-offs trying to please all of them. Evolent Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Evolent Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Dan McCarthy | CEO President | Profile | |
| Seth Blackley | Chief Executive Officer, Co-Founder, Director | Profile | |
| Frank Williams | Co-Founder, CEO, Director and Chairman of Nominating and Governance Committee | Profile | |
| Nicholas McGrane | Executive Vice President of Corporate Performance | Profile | |
| Scott Pritchard | President Suite | Profile | |
| John Johnson | Chief Financial Officer | Profile | |
| Thomas Peterson | Chief Operating Officer | Profile | |
| Steve Tutewohl | Chief Operating Officer | Profile | |
| Bridget Duffy | Independent Director | Profile | |
| Bruce Felt | Independent Director | Profile | |
| Cheryl Scott | Lead Independent Director | Profile | |
| David Farner | Director | Profile | |
| Diane Holder | Director | Profile | |
| Michael DAmato | Independent Director | Profile | |
| Kim Keck | Independent Director | Profile | |
| Jonathan JD | General Officer | Profile | |
| Geoff McHugh | Chief Officer | Profile | |
| Katie Cook | Chief Officer | Profile | |
| Robert Cruz | Chief Officer | Profile | |
| John MD | Chief Officer | Profile | |
| Tunde Sotunde | Independent Director | Profile | |
| Andrew MD | Chief Advisor | Profile | |
| MAAA FSA | Chief Officer | Profile | |
| Emily Rafferty | Executive Success | Profile | |
| M Duffy | Independent Director | Profile | |
| John Way | Chief Suite | Profile | |
| Craig Barbarosh | Independent Director | Profile | |
| Jordan Silvergleid | Chief Officer | Profile | |
| Jonathan Weinberg | General Counsel | Profile | |
| Aammaad Shams | Interim Principal Accounting Officer and Corporate Controller | Profile | |
| Jessica Somers | Sr Devel | Profile | |
| Seth Frank | Vice Relations | Profile | |
| Mark Mannion | Senior Finance | Profile | |
| Mario Ramos | Chief Officer | Profile | |
| Peter Grua | Independent Director | Profile | |
| David Lim | Chief Officer | Profile | |
| Kali Beyah | Chief Officer | Profile | |
| Jessica White | Chief Officer | Profile | |
| MPH MD | Chief Officer | Profile |
About Evolent Health Management Performance
The success or failure of an entity such as Evolent Health often depends on how effective the management is. Evolent Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Evolent management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Evolent management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.08) | (0.08) | |
| Return On Capital Employed | (0.02) | (0.02) | |
| Return On Assets | (0.02) | (0.02) | |
| Return On Equity | (0.07) | (0.07) |
Evolent Health Workforce Analysis
Traditionally, organizations such as Evolent Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Evolent Health within its industry.Evolent Health Manpower Efficiency
Return on Evolent Health Manpower
| Revenue Per Employee | 567.7K | |
| Revenue Per Executive | 65.5M | |
| Net Loss Per Employee | 13.7K | |
| Net Loss Per Executive | 1.6M |
Complementary Tools for Evolent Stock analysis
When running Evolent Health's price analysis, check to measure Evolent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolent Health is operating at the current time. Most of Evolent Health's value examination focuses on studying past and present price action to predict the probability of Evolent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolent Health's price. Additionally, you may evaluate how the addition of Evolent Health to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |